Literature DB >> 9323850

Control of scrapie eventually possible?

B E Schreuder1, L J van Keulen, M A Smits, J P Langeveld, J A Stegeman.   

Abstract

After a brief description of the scrapie situation in the Netherlands, the technical progress made in aspects of scrapie diagnosis is reported. Emphasis is placed on the use of immuno-histochemistry (IHC) in the post-mortem histological diagnosis and on the recently published preclinical test for scrapie, in which IHC is applied to tonsillar biopsies. These two approaches use the same IHC technique and enable us to confirm suspected scrapie in individual animals, and for certain genotypes even in the preclinical phase. The tonsillar biopsy method could eventually lead to an infection- or PrPSc-detection method at flock level. Further work is required, including validation of the assay for various breeds, genotypes, and strains of the agent, and the conversion of the test into a more practical assay. The article continues with a discussion of several scrapie control strategies, describing briefly schemes tried in various countries, and elaborates on a proposed scrapie control scheme that could be suitable for the Netherlands. This scheme is essentially based on breeding for resistance, based on PrP genotyping.

Entities:  

Mesh:

Year:  1997        PMID: 9323850     DOI: 10.1080/01652176.1997.9694752

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  3 in total

1.  Comparative PRNP genotyping of U.S. cattle sires for potential association with BSE.

Authors:  Christopher M Seabury; James E Womack; Jorge Piedrahita; James N Derr
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

2.  Eradication of scrapie with selective breeding: are we nearly there?

Authors:  Marielle B Melchior; Jack J Windig; Thomas J Hagenaars; Alex Bossers; Aart Davidse; Fred G van Zijderveld
Journal:  BMC Vet Res       Date:  2010-05-04       Impact factor: 2.741

3.  Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases.

Authors:  A Aguzzi
Journal:  Dialogues Clin Neurosci       Date:  2001-03       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.